WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MAY ISSUE PUBLISHED
  • May Issue has been successfully launched on 1 May 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

PHARMACOVIGILANCE: PRESENT SCENERIO AND FUTURE CHALLENGES

Malarvizhi P.* and Vaishnavi Devi C.

ABSTRACT

Pharmacovigilance is meant to cover the collection of information on adverse drug reaction at pre or post marketing stage. The most important relationship between patients and other healthcare professionals for better outcome in promoting the safety of medicine throughout their lifecycle. The mainly focusing on this review is promotional activities of PVPI on the role and responsibilities of regulatory authority and organization ,importance of pharmacovigilance ,status of AMC and programme communication used PV in india and current challenges and overcome and future prospects with respect to Indian context.

Keywords: Pharmacovigilance, Regulatory authority, Organization, AMC.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More